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ABSTRACT 
Background: Hyperlipidaemia is a significant risk factor for cardiovascular disease. However, 
adherence to lipid-lowering therapy is often unsatisfactory due to a combination of patient 
factors, therapy, socio-economic and health system-related factors.  
Aims: to identify the prevalence of adherence to lipid-lowering therapy, the factors 
contributing to non-adherence and knowledge regarding hyperlipidaemia and its’ treatment 
among Malaysian patients with hyperlipidemia.  
Methods: A quantitative study using a cross-sectional survey was carried out in an urban 
primary care clinic in August 2015. Patients on lipid-lowering therapy for ≥ 1 year aged ≥ 18 
years were selected using simple random sampling. consenting patients answered a self-
administered questionnaire (in Malay/English) which included socio-demographic profile, 
hyperlipidaemia profile, adherence to lipid-lowering therapy (using the Morisky Medication 
Adherence scale-8; score ≥ 6 taken as adherent), reasons leading to non-adherence, 
knowledge regarding hyperlipidaemia and its’ treatment, and use of non-allopathic medicine.  
Results: the response rate was 90.7%. the prevalence of adherence to lipid-lowering therapy 
was 82.4%. “the most common reasons for non-adherence was being worried about side 
effect of lipid-lowering agent (71.4%), followed by the need to take too many drugs in a day 
(61.4%) and negative influences by friends, relative and mass media (60%)”. Factors 
associated with non-adherence include male gender, on longer duration of therapy, less 
frequency of follow-up, less number of follow-up clinics, taking medication at night/random 
timing and having lower knowledge scores.  
Conclusion: Overall the prevalence of adherence was high in patients with hyperlipidaemia. 
Interventions to boost adherence should target those who were identified as non-adherent. 
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